| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10232126 | Current Opinion in Biotechnology | 2013 | 11 Pages |
Abstract
⺠Highly variable and complex pathogens remain challenging vaccine targets. ⺠Systems biology and reverse vaccinology continue to foster success. ⺠New ways of presenting conserved, functionally critical epitopes hold promise. ⺠Adjuvant systems allow for enduring, native antigen presentation. ⺠An ideal vaccine provides synergy between innate, cellular, and humoral immunity.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Sebastian K Grimm, Margaret E Ackerman,